I TRIGLICERIDI COME FATTORE DI RISCHIO CARDIOVASCOLARE

Abstract

Triglycerides and cardiovascular prevention have become increasingly important, especially in diabetic patients who continue to have a higher cardiovascular risk compared to the general population. Elevated triglycerides, part of the typical “diabetic dyslipidemia”, are often under-recognized but play a crucial role in cardiovascular risk. Treatments focusing on triglycerides as fenofibrate and omega-3 fatty acids, particularly Icosapent Ethyl (IPE), have shown to reduce cardiovascular events in well-selected patients. This review addressed how and why it is important to consider hypertriglyceridemia in cardiovascular prevention among patients with diabetes.